CHEMBL1253490 (+/-)-threo-Methylphenidate amide BDBM50327105
(+/-)-threo-N-(2-Methylpyridine)methylphenidate CHEMBL1255015 BDBM50327126
(+/-)-threo-N-(2-Methylthiopene)methylphenidate CHEMBL1254843 BDBM50327131
(+/-)-threo-N-(2-Phenylethyl)methylphenidate CHEMBL1254101 BDBM50327116
(+/-)-threo-N-(3-Methylfuran)methylphenidate BDBM50327132 CHEMBL1254842
(+/-)-threo-N-(3-Methylpyridine)methylphenidate CHEMBL1255014 BDBM50327127
(+/-)-threo-N-(3-Methylthiopene)methylphenidate BDBM50327130 CHEMBL1254928
(+/-)-threo-N-(3-Phenylpropyl)methylphenidate CHEMBL1254196 BDBM50327114
(+/-)-threo-N-(4-Chlorobenzyl)methylphenidate BDBM50327122 CHEMBL1253840
(+/-)-threo-N-(4-Methoxybenzyl)methylphenidate BDBM50327124 CHEMBL1255100
(+/-)-threo-N-(4-Methylpyridine)methylphenidate BDBM50327128 CHEMBL1254930
(+/-)-threo-N-(4-Phenylbutyl)methylphenidate CHEMBL1254100 BDBM50327117
BDBM50327109 (+/-)-threo-N-(4-Isothiocyanantobenzyl)methylphenidate CHEMBL1254360
BDBM50327118 CHEMBL1254009 (+/-)-threo-N-(5-Phenylpentyl)methylphenidate
BDBM50327120 CHEMBL1253919 (+/-)-threo-N-(2-Chlorobenzyl)methylphenidate
BDBM50327129 CHEMBL1254929 (+/-)-threo-N-(2-Methylfuran)methylphenidate
CHEMBL1253839 BDBM50327123 (+/-)-threo-N-(4-Nitrobenzyl)methylphenidate
CHEMBL1254008 BDBM50327119 (+/-)-threo-N-(6-Phenylhexyl)methylphenidate
CHEMBL1254195 (+/-)-threo-N-(3-Chlorobenzyl)methylphenidate BDBM50327115
CHEMBL1255099 (+/-)-threo-N-((5-Chlorothiophene-2-yl)methyl)methylphenidate BDBM50327125
(S)-Phenyl-(S)-piperidin-2-yl-acetic acid methyl ester; hydrochloride CHEMBL542556 BDBM50050098 METHYLPHENIDATE
METHYLPHENIDATE methyl (S)-phenyl[(S)-piperidin-2-yl]acetate methyl (2S)-phenyl[(2S)-piperidin-2-yl]acetate BDBM50062909
CHEMBL827 methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate METHYLPHENIDATE BDBM50062915 methyl (R)-phenyl[(R)-piperidin-2-yl]acetate
methyl phenidylacetate BDBM50062912 methyl alpha-phenyl-alpha-(2-piperidyl)acetate alpha-phenyl-2-piperidineacetic acid methyl ester methyl phenyl(piperidin-2-yl)acetate methylphenidan methyl alpha-phenyl-alpha-2-piperidinylacetate CHEMBL796 Methylphenidate
- Schweri, MM; Deutsch, HM; Massey, AT; Holtzman, SG Biochemical and behavioral characterization of novel methylphenidate analogs. J Pharmacol Exp Ther 301: 527-35 (2002)
- Lapinsky, DJ; Yarravarapu, N; Nolan, TL; Surratt, CK; Lever, JR; Tomlinson, M; Vaughan, RA; Deutsch, HM Evolution of a Compact Photoprobe for the Dopamine Transporter Based on (±)-threo-Methylphenidate. ACS Med Chem Lett 3: 378-382 (2012)
- Misra, M; Shi, Q; Ye, X; Gruszecka-Kowalik, E; Bu, W; Liu, Z; Schweri, MM; Deutsch, HM; Venanzi, CA Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem 18: 7221-38 (2010)
- Patrick, KS; Williard, RL; VanWert, AL; Dowd, JJ; Oatis, JE; Middaugh, LD Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem 48: 2876-81 (2005)
- Davies, HM; Hopper, DW; Hansen, T; Liu, Q; Childers, SR Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites. Bioorg Med Chem Lett 14: 1799-802 (2004)
- Meltzer, PC; Wang, P; Blundell, P; Madras, BK Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate. J Med Chem 46: 1538-45 (2003)
- Froimowitz, M; Gu, Y; Dakin, LA; Nagafuji, PM; Kelley, CJ; Parrish, D; Deschamps, JR; Janowsky, A Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter. J Med Chem 50: 219-32 (2007)
- Froimowitz, M; Deutsh, HM; Shi, Q; Wu, K; Glaser, R; Adin, I; George, C; Schweri, MM Further evidence for a dopamine reuptake pharmacophore. The effect of N-methylation on Threo-methylphenidate and its analogs Bioorg Med Chem Lett 7: 1213-1218 (1997)
- Kim, DI; Deutsch, HM; Ye, X; Schweri, MM Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate. J Med Chem 50: 2718-31 (2007)
- Deutsch, HM; Shi, Q; Gruszecka-Kowalik, E; Schweri, MM Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs. J Med Chem 39: 1201-9 (1996)
- Lapinsky, DJ; Velagaleti, R; Yarravarapu, N; Liu, Y; Huang, Y; Surratt, CK; Lever, JR; Foster, JD; Acharya, R; Vaughan, RA; Deutsch, HM Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling. Bioorg Med Chem 19: 504-12 (2011)
- Ukairo, OT; Bondi, CD; Newman, AH; Kulkarni, SS; Kozikowski, AP; Pan, S; Surratt, CK Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. J Pharmacol Exp Ther 314: 575-83 (2005)